Neuroleptic malignant syndrome.
D014150:Antipsychotic Agents / Q000009:adverse effects; D003620:Dantrolene / Q000627:therapeutic use; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D008305:Malignant Hyperthermia; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology / Q000628:therapy
D014150:Antipsychotic Agents; D003620:Dantrolene; D004298:Dopamine